Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Catalyst Grant : Maternal Health: From Pre-Conception to the Empty Nest

University of Alberta

$67,786.00

Molecular diagnostics to enhance detection of malaria in pregnancy

FY 2010-11

Summary
Malaria is caused by a parasite that infects our blood. Pregnant women are at especially high risk for malaria. Infection can cause severe disease in the mother, as well as placental or congenital malaria which can have serious consequences for the development of the fetus and the health of the newborn. The diagnosis of maternal, placental and congenital malaria occurs at the time of delivery and relies on screening methods that are not very sensitive. A new test that directly detects and quantifies parasite DNA in the blood may be far more sensitive. In this project, we will test matched blood samples from mothers, umbilical cord and placenta collected at delivery from patients in a malaria endemic region of Colombia. We will compare the performance of this test with more traditional methods. We will also evaluate a new antibody-based tool to screen for malaria exposure in utero. Our goal is to identify the optimum methods for diagnosis of malaria at the time of delivery to ensure healthy mothers and babies.
Program
Catalyst Grant : Maternal Health: From Pre-Conception to the Empty Nest
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
212798
Name
Yanow Stephanie K
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Maternal Health Initiative
Projecttitle
Molecular diagnostics to enhance detection of malaria in pregnancy
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$67,786
Cihrequipment2
$0
Programname2
Catalyst Grant : Maternal Health: From Pre-Conception to the Empty Nest
Keyworddelim
Colombia; Diagnosis; Malaria; Molecular Diagnostics; Mothers; Placental Malaria; Plasmodium Vivax; Pregnancy; Real-Time Pcr; Serology
Abstract
Malaria is caused by a parasite that infects our blood. Pregnant women are at especially high risk for malaria. Infection can cause severe disease in the mother, as well as placental or congenital malaria which can have serious consequences for the development of the fetus and the health of the newborn. The diagnosis of maternal, placental and congenital malaria occurs at the time of delivery and relies on screening methods that are not very sensitive. A new test that directly detects and quantifies parasite DNA in the blood may be far more sensitive. In this project, we will test matched blood samples from mothers, umbilical cord and placenta collected at delivery from patients in a malaria endemic region of Colombia. We will compare the performance of this test with more traditional methods. We will also evaluate a new antibody-based tool to screen for malaria exposure in utero. Our goal is to identify the optimum methods for diagnosis of malaria at the time of delivery to ensure healthy mothers and babies.
Competitiondate
201009
Approvedterm2
1 yr 0 mth
Pinamesdelim
Yanow, Stephanie K
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Human Dev &Child &Yth~ $67,786~ $0~
University of Alberta - $67,786 Grant (2010-11) | Canada Spends